CoreAge Rx vs vyrarx

The verdict

CoreAge Rx edges out vyrarx on the Mom-Tested Score, 94 to 36 (A vs C). Moms who want a flat, no-teaser price, both molecules available, and a signup you can genuinely finish while the baby sleeps — without a phone-tag scheduling loop.

vyrarx is still a genuine option — publishes a floor and calls it a price — read live on 2026-08-21 the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it came back clean on the FDA's warning-letter list. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing. Weigh the six mom factors below against your own priorities.